Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Turk Ilac ve Serum Sanayi AS
Retained Earnings
Turk Ilac ve Serum Sanayi AS
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
|
Retained Earnings
₺225.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
Deva Holding AS
IST:DEVA.E
|
Retained Earnings
₺20.5B
|
CAGR 3-Years
35%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
|
|
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IST:GENIL.E
|
Retained Earnings
₺4.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
Turk Ilac ve Serum Sanayi AS
Glance View
Türk Ilaç ve Serum Sanayi AS engages in the manufacture of medical drugs. The main activity of the Company is to manufacture and sell all kinds of tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids and other chemical substances. The firm also acts as the representative or sales agency of other domestic and foreign pharmaceutical companies, as well as importing and marketing veterinary, cosmetics and pesticides. Turk Ilac manufactures in accordance with Current Good Manufacturing (GMP) and Good Laboratory Practice (GLP) principles with its approximately 300 employees in its facilities on a total area of 56.000 square meters in the Ankara - Akyurt region.
See Also
What is Turk Ilac ve Serum Sanayi AS's Retained Earnings?
Retained Earnings
225.8m
TRY
Based on the financial report for Dec 31, 2025, Turk Ilac ve Serum Sanayi AS's Retained Earnings amounts to 225.8m TRY.
What is Turk Ilac ve Serum Sanayi AS's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
48%
Over the last year, the Retained Earnings growth was -65%. The average annual Retained Earnings growth rates for Turk Ilac ve Serum Sanayi AS have been 19% over the past three years , 48% over the past five years .
